Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04091659 · ClinicalTrials.gov registry record · NA
Use of Virtual Reality for Overdose Management Educational Trainings
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 98
- Enrollment target
NCT04091659: Completed NA study, sponsored by University of Pennsylvania.
NCT04091659 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 98 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04091659, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 98 participants
- Enrollment target
Study Summary
This cluster-randomized trial will compare changes in attitudes and knowledge on administering naloxone based on exposure to either a virtual reality educational training or the current standard educational trainings (e.g. on-line videos, printed information handouts) offered at local libraries. Individuals attending local library's naloxone training days will voluntarily complete an anonymous validated survey pre and post attending either the virtual reality or standard educational training.
Interventions
- OTHER Virtual Reality Education
- OTHER Standard Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2019-09-18 |
| Est. Completion | 2020-01-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04091659
The ClinicalTrials.gov registry entry for NCT04091659 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Virtual Reality Education is the first listed.
NCT04091659 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04091659 about?
NCT04091659 is a clinical study titled "Use of Virtual Reality for Overdose Management Educational Trainings". This cluster-randomized trial will compare changes in attitudes and knowledge on administering naloxone based on exposure to either a virtual reality educational training or the current standard educational trainings (e.g. on-line videos, printed information handouts) offered at local libraries. Ind...
What is the current status of trial NCT04091659?
This trial is currently completed. It is a NA study. The enrollment target is 98 participants. The study started on 2019-09-18. Estimated completion is 2020-01-16.
What interventions are being tested in trial NCT04091659?
The interventions under investigation include: Virtual Reality Education (OTHER), Standard Education (OTHER).
Who is sponsoring clinical trial NCT04091659?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.